BS2661

antibody from Bioworld Technology, Inc
Targeting: TSC22D1 MGC17597, TGFB1I4, TSC22
Provider product page for BS2661
Western blot
Immunocytochemistry
Immunohistochemistry

Antibody data

Product number
BS2661 - Provider product page
Provider
Bioworld Technology, Inc
Proper citation
Bioworld Technology Cat#BS2661, RRID:AB_1663774
Product name
TSC22 (E73) polyclonal antibody
Antibody type
Polyclonal
Antigen
Synthetic peptide, corresponding to amino acids 41-93 of Human TSC22.
Description
Transforming growth factor-ÉÇ-stimulated clone-22 (TSC-22) acts as a transcriptionalregulator to modulate cell growth and differentiation and cell death. TSC-22 contains a leucine zipper domain as well as a nuclear export signal, resulting in cytoplasmic localization in living cells. However, concomitant with the induction of apoptosis, TSC-22 translocates from the cytoplasm to the nucleus and shows transcriptional regulatory activity. TSC-22 acts as a major downstream component in the TGF-ÉÇ pathway, and also the PPARÎÛ signalling pathway. The association of these two pathways with tumor suppression, and the significant downregulation of TSC-22 mRNA in various cancer types, such as brain and salivary gland tumors, imply an antiproliferative role for TSC-22.
Reactivity
Human, Mouse, Rat
Host
Rabbit
Isotype
IgG
Vial size
100ul
Concentration
1 mg/ml
Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
TSC22D1 protein structure - BS2661 shown in red.